Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMPAGLIFLOZIN Cause Candida infection? 157 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 157 reports of Candida infection have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.4% of all adverse event reports for EMPAGLIFLOZIN.

157
Reports of Candida infection with EMPAGLIFLOZIN
0.4%
of all EMPAGLIFLOZIN reports
2
Deaths
67
Hospitalizations

How Dangerous Is Candida infection From EMPAGLIFLOZIN?

Of the 157 reports, 2 (1.3%) resulted in death, 67 (42.7%) required hospitalization, and 17 (10.8%) were considered life-threatening.

Is Candida infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 157 reports have been filed with the FAERS database.

What Other Side Effects Does EMPAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,644) Fungal infection (1,941) Blood glucose increased (1,797) Euglycaemic diabetic ketoacidosis (1,769) Weight decreased (1,661) Urinary tract infection (1,439) Ketoacidosis (1,411) Dizziness (1,372) Nausea (1,333) Vomiting (1,201)

What Other Drugs Cause Candida infection?

PREDNISONE (939) METHOTREXATE (782) RITUXIMAB (684) CYCLOPHOSPHAMIDE (662) TACROLIMUS (656) METHYLPREDNISOLONE (590) SECUKINUMAB (569) ADALIMUMAB (510) DEXAMETHASONE (506) PREDNISOLONE (499)

Which EMPAGLIFLOZIN Alternatives Have Lower Candida infection Risk?

EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN EMPAGLIFLOZIN vs EMSAM EMPAGLIFLOZIN vs EMTRICITABINE

Related Pages

EMPAGLIFLOZIN Full Profile All Candida infection Reports All Drugs Causing Candida infection EMPAGLIFLOZIN Demographics